ExploreWatchlistsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Return on Assets

KYORIN Pharmaceutical Co., Ltd. (4569)

Market cap
¥74.2B
P/E ratio
44x
Kyorin Pharmaceutical manufactures and sells pharmaceutical products through an integrated system spanning from production to sales across Japan.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndReturn on Assets (Million JPY)YoY (%)
Mar 31, 20262.2-56.03%
Mar 31, 20254.9+62.46%
Mar 31, 20243+11.07%
Mar 31, 20232.7+16.81%
Mar 31, 20222.3-35.91%
Mar 31, 20213.6+1.40%
Mar 31, 20203.6-3.51%
Mar 31, 20193.7+10.12%
Mar 31, 20183.4-10.16%
Mar 31, 20173.7-47.77%
Mar 31, 20167.2

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat